|
stomach. A Clinical and pathological study of one hundred an fifty-three cases. Cancer. 1962-15:456-467.
3. FENOGLIO CECILIA. Gastrointestinal Pathology. An Atlas and Text. 1999. Lippincott Williams y Wilkins.
4. WHO Classification Tumours of the Digestive System Lyon 2000 IARC Press.
5. ABRAHAM SC, MONTGOMERY EA, SINGH VK, et al. Gastric adenomas: Intestinal type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002; 26:1276-1285.
6. BORCH K. Epidemiologic, clinicopathologic, and economic aspects of gastroscopic screening of patients with pernicious anemia. Scand J Gastroenterol 1986; 21:21-30.
7. GAITINI D, KLEINHAUS U, MUNICHOR M, et al. Villois tumors of the stomach. Gastrointest Radiol 1988;13:105-8.
8. GINSBERG GG, AL-KAWAS FH, FLEISCHER DE, et al. Gastric polys: relationship of size and histology to cancer risk.Am J Gastroenterol 1996;91:714-7.
9. ITO H, YOKOZAKI H, ITO M, et al. Papillary adenoma of the stomach: pathologic and immunohis-tochemical study. Arch Pathol Lab Med 1989:113:1030-4.
10. KOLODZIEJCZYK P, YAO T, OYA M, et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation: an immunohistochemical and histochemical analysis. Cancer 1994;74:2896-907.
11. LAUWERS GY, WAHL SJ, MELAMED J, et al. P53 expression in pre-cancerous gastric lesions: an immunohistochemical study of Pab 1801 monoclonal antibody on ademonatous and hyperplastix gastric polyps. Am J Gastroenterol 1993;88:1916-9.
12. LAXEN F, SIPPONEN P, IHAMAKI T, et al. Gastric polyps: their morphologic and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand A 1982;90:221-8.
13. NAKAMURA K, SAKAGUCHI H, ENJOJO M. Depressed adenoma of the stomach. Cancer 1988;62:2197-202.
14. ORLOWSKA J, PIETROW D. Multifocal gastric carcinoma arising from hyperplastic and ademonatous polyps. Am J Gastroenterol 1990;85:1629-34.
15. ORLOWSKA J, JAROSZ D, PACHLEWSKI J, et al. Malignant transformation of benign ephitelial gastric polyps. Am J Gastroenterol 1995;60:2152-9.
16. PISANO R, LLORENS P, BAKCHOUSE C, et al. Anatomopathologic study of 86 gastric adenomas: experience in 14 years. Rev Med Chil 1996;124:204-8.
17. SAKURAI S, SANO T, MAESHIMA A, et al. Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations. Virchows Arch 1995;427:119-24.
18. SAKURI S, SANO T, NAKAJIMA T. Clinicopathologic and molecular biologic studies gastric adenomas with special reference to p53 abnormality. Pathol Int 1995;45:51-7.
19. STOLTE M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 1995;24:32-7.
20. TSUJITANI S, FURUSAWA M, HAYASHI I. Morphological factors aid in therapeutic decisions concerning gastric adenomas. Hepatogas-troenterology 1992;39:56-8.
21. MING SC, GOLDMAN H, Gastric polyps. A histogenetic classification and its relation to carcinoma. Cancer 1965;18:721-6.
22. REMMELE W, KOLB EF. Malignant transformation of hyperplasiogenic polyps of the stomach. Endoscopy 1978;10:63-5.
23. NAGAYO T. Histological criteria of malignant transformation of gastric polyp ans its results. Stomach Intestine 1975;10:301-8 (in Japananese with English Abstract).
24. DAIBO M, ITABASHI M, HIROTA T. Malignant transformation of Gastric Hyperplastic Polyps. Am J Gastroenterol 1987;82:1016-1025.
25. BARREDA F, SÁNCHEZ LJ. Tratamiento endoscópico del Cáncer Gástrico Temprano y lesiones pre malignas gástricas mediante mucosectomía. Rev Gastroent Perú 1998;18:214-226.
26. SÁNCHEZ J, et al. Displasias y Carcinomas del Estómago: Identificación de la Proteína p53. Acta Cancerológica 1998;28:5-9.
27. SÁNCHEZ J. Pólipos Hiperplásicos del Estómago con transformación maligna en Adenocarcinoma Consideraciones sobre la Histogénesis. Acta Cancerológica 2002;31:7-14.
|
|
